[an error occurred while processing this directive]
Skip to Main Content

Latest News

Advertise Here
September 10, 2010

Appeals Court Lifts Stem Cell Injunction

Ruling: Federal funding can resume for now

Britt E. Erickson

  • Print this article
  • Email the editor

Latest News

October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

Lamberth U.S. District Court

In a move that caught many people by surprise, a federal appeals court on Sept. 9 lifted an injunction that prohibited the National Institutes of Health from funding human embryonic stem cell research. The court granted a request from the Justice Department to lift the injunction while a lawsuit opposing this type of stem cell research is being litigated.

The lawsuit was filed by two researchers who claim that NIH’s stem cell policy violates a law known as the Dickey-Wicker Amendment. That law prohibits federal funding of any research that destroys human embryos. On Aug. 23, Chief Judge Royce C. Lamberth of the Federal District Court for the District of Columbia issued a preliminary injunction in the case, ordering NIH to halt funding for all human embryonic stem cell research until the lawsuit is resolved (C&EN, Aug. 30, page 4).

Several scientists and government lawyers spoke out about the dire consequences of the injunction, claiming that it will terminate many stem cell research projects and stall new treatments for diabetes, spinal cord injuries, and other diseases. “The injunction threatens to stop progress in one of the most encouraging areas of biomedical research, just as scientists are gaining momentum—and squander the investment we have already made,” NIH Director Francis S. Collins said in a statement on Aug. 26. NIH has spent more than $546 million on human embryonic stem cell research since 2001, Collins noted.

Nonetheless, Lamberth was not convinced that his injunction would cause major disruption. “Defendants are incorrect about much of their ‘parade of horribles’ that will supposedly result from this Court’s preliminary injunction,” he wrote in a decision on Sept. 7. But just two days later, the appeals court reversed Lamberth’s decision.

Many supporters of stem cell research called the appeals court ruling a victory. “It is crucial that federal funding for human embryonic stem cell research be restored permanently, and this stay is a step in that direction,” Lisa Hughes, president of the Coalition for the Advancement of Medical Research, said in a statement. She urged Congress to “move swiftly to resolve this issue and secure the future of this important biomedical research.”

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!